This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2002
Title: Innovations by Geoffrey Lee in Pharmaceutical Technology
Introduction
Geoffrey Lee is a notable inventor based in Buckenhof, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative pellet formulations. With a total of 2 patents to his name, his work focuses on enhancing the efficiency and effectiveness of drug delivery systems.
Latest Patents
Geoffrey Lee's latest patents include "Rapidly Disintegrating Coated Pellets with Delayed Release" and "Fast Decomposing Pellets." Both inventions concern pharmaceutical forms of administration in the shape of pellets that contain a retarding agent. The unique aspect of these pellets is that the release rate of the active substance is not delayed or is substantially identical compared to corresponding pellets that do not contain a retarding agent. Notably, the release rate of these rapidly disintegrating pellets is at least about 90% within a time period of 30 minutes. Additionally, these patents also cover the processes for the production of these innovative pellets.
Career Highlights
Geoffrey Lee is currently associated with Roche Diagnostics GmbH, where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in developing new methods for drug delivery that enhance patient outcomes.
Collaborations
Geoffrey has collaborated with several professionals in his field, including Rolf-Dieter Gabel and Michaela Opitz. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Geoffrey Lee's contributions to pharmaceutical technology through his innovative pellet formulations demonstrate his commitment to improving drug delivery systems. His patents reflect a significant advancement in the field, showcasing his expertise and dedication to enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
